export interface SchemaScript {
  id: string
  jsonLd: Record<string, any>
}

export const BLOG_SCHEMAS: Record<string, SchemaScript[]> = {
  'glp-1-gip-agonists-semaglutide-tirzepatide-retatrutide-research': [
    {
      id: 'article-schema-glp1',
      jsonLd: {
        '@context': 'https://schema.org',
        '@type': 'Article',
        headline: 'The Ultimate Guide to GLP-1 & GIP Agonists: Semaglutide, Tirzepatide, and Retatrutide in Research',
        description: 'An in-depth, systematic comparison of Semaglutide, Tirzepatide, and Retatrutide. Explore the mechanisms of action, receptor affinities, and research applications.',
        author: {
          '@type': 'Organization',
          name: 'Certified Aminos Research',
        },
        publisher: {
          '@type': 'Organization',
          name: 'Certified Aminos',
          logo: {
            '@type': 'ImageObject',
            url: 'https://certifiedaminos.com/icon.png',
          },
        },
        datePublished: '2026-08-04T08:00:00Z',
      },
    },
    {
      id: 'faq-schema-glp1',
      jsonLd: {
        '@context': 'https://schema.org',
        '@type': 'FAQPage',
        mainEntity: [
          {
            '@type': 'Question',
            name: 'What is the standard research dosage for Semaglutide in early phase models?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Early phase models typically begin with a titration protocol starting at 0.25mg per week to observe gastrointestinal tolerability, eventually scaling to 2.4mg per week for maximum metabolic efficacy.',
            },
          },
          {
            '@type': 'Question',
            name: 'How does Tirzepatide dual-agonism affect nausea profiles compared to Semaglutide?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Research suggests that GIP agonism possesses anti-emetic properties. Consequently, Tirzepatide often displays a comparable or slightly improved nausea profile relative to high-dose Semaglutide.',
            },
          },
          {
            '@type': 'Question',
            name: 'Why include Glucagon agonism in Retatrutide?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Glucagon increases basal metabolic rate and promotes lipolysis. By combining it with GLP-1 and GIP, researchers can induce a higher caloric deficit via energy expenditure without sacrificing glycemic control.',
            },
          },
          {
            '@type': 'Question',
            name: 'Can these peptides be reconstituted with standard BAC water?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Yes. Lyophilized Semaglutide, Tirzepatide, and Retatrutide must be reconstituted using Bacteriostatic Water to ensure sterility and stability during the research phase.',
            },
          },
          {
            '@type': 'Question',
            name: 'What is the shelf life of these peptides post-reconstitution?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Once reconstituted with BAC water and stored appropriately in refrigeration (2-8°C), the chemical integrity of these peptides is generally maintained for approximately 28 to 30 days.',
            },
          },
          {
            '@type': 'Question',
            name: 'Are there specific storage requirements for lyophilized vials?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Lyophilized vials should be kept in a cold, dark environment, ideally in a freezer at -20°C for long-term storage, preventing premature peptide degradation.',
            },
          },
          {
            '@type': 'Question',
            name: 'How does the half-life of Tirzepatide compare to Retatrutide?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Both Tirzepatide and Retatrutide exhibit extended half-lives of roughly 5 to 7 days, primarily due to their engineered fatty acid chains that facilitate strong binding to serum albumin.',
            },
          },
          {
            '@type': 'Question',
            name: 'Do GLP-1 agonists cross the blood-brain barrier?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Yes. GLP-1 receptors are expressed in the central nervous system, particularly the hypothalamus. Peptides like Semaglutide cross the blood-brain barrier to modulate satiety.',
            },
          },
          {
            '@type': 'Question',
            name: 'What role does the DPP-4 enzyme play in this research?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Native GLP-1 has a half-life of less than 2 minutes due to rapid cleavage by the DPP-4 enzyme. All modern incretin mimetics are synthetically altered to resist DPP-4 degradation.',
            },
          },
          {
            '@type': 'Question',
            name: 'Can these peptides be stacked with other metabolic compounds?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'While research protocols vary, combining incretins with compounds like MOTS-c or AOD9604 is an active area of investigation for synergistic metabolic and mitochondrial benefits.',
            },
          },
          {
            '@type': 'Question',
            name: 'Is Retatrutide more potent than Tirzepatide?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Current data indicates that Retatrutide tri-agonism leads to a significantly steeper mass reduction curve compared to Tirzepatide, primarily due to the added energy expenditure mechanism of the Glucagon receptor.',
            },
          },
          {
            '@type': 'Question',
            name: 'What is the impact of Tirzepatide on lean muscle mass?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Significant mass reduction universally carries the risk of muscle catabolism. Researchers often monitor lean body mass carefully when administering Tirzepatide.',
            },
          },
          {
            '@type': 'Question',
            name: 'Does Semaglutide impact cardiovascular models?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Extensive models indicate Semaglutide provides cardiovascular protective effects, lowering the incidence of major adverse cardiovascular events (MACE) in applicable research cohorts.',
            },
          },
          {
            '@type': 'Question',
            name: 'How should one prepare a 5mg Tirzepatide vial?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'A standard protocol involves slowly adding 1mL or 2mL of Bacteriostatic Water to the 5mg vial, gently swirling (never shaking) until the lyophilized powder is completely dissolved.',
            },
          },
          {
            '@type': 'Question',
            name: 'Where is the most accurate place to source research-grade incretins?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'High-purity, third-party tested peptides are paramount for accurate research. Reliable scientific suppliers provide detailed Certificates of Analysis (COA) verifying purity.',
            },
          },
        ],
      },
    },
  ],
  'tissue-repair-synergy-bpc-157-tb-500-ghk-cu': [
    {
      id: 'article-schema-tissue',
      jsonLd: {
        '@context': 'https://schema.org',
        '@type': 'Article',
        headline: 'Tissue Repair Synergy: Exploring BPC-157, TB-500, and GHK-Cu in Advanced Protocols',
        description: 'Discover the profound synergistic effects of BPC-157, TB-500, and GHK-Cu. This comprehensive guide outlines the molecular mechanisms behind advanced tissue repair.',
        author: {
          '@type': 'Organization',
          name: 'Certified Aminos Research',
        },
        publisher: {
          '@type': 'Organization',
          name: 'Certified Aminos',
          logo: {
            '@type': 'ImageObject',
            url: 'https://certifiedaminos.com/icon.png',
          },
        },
        datePublished: '2026-08-04T08:00:00Z',
      },
    },
    {
      id: 'faq-schema-tissue',
      jsonLd: {
        '@context': 'https://schema.org',
        '@type': 'FAQPage',
        mainEntity: [
          {
            '@type': 'Question',
            name: 'Why is BPC-157 often combined with TB-500?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'They act synergistically on different pathways. BPC-157 focuses on angiogenesis and gut lining repair, while TB-500 focuses on actin up-regulation and cellular migration.',
            },
          },
          {
            '@type': 'Question',
            name: 'Is BPC-157 effective when administered systemically?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Yes. While site-specific administration is common in localized tendon injuries, BPC-157 exhibits systemic effects, promoting healing across the entire organism regardless of the injection site.',
            },
          },
          {
            '@type': 'Question',
            name: 'Does GHK-Cu cause localized irritation?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Because it is a copper-binding peptide, subcutaneous administration of GHK-Cu can sometimes cause localized pain or irritation at the injection site in research models.',
            },
          },
          {
            '@type': 'Question',
            name: 'How often is TB-500 administered in a standard research protocol?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Due to its longer half-life relative to BPC-157, TB-500 is typically administered twice weekly during the acute loading phase, followed by a once-weekly maintenance phase.',
            },
          },
          {
            '@type': 'Question',
            name: 'Can these three peptides be mixed in the same syringe?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'While chemically stable in isolation, combining multiple peptides in a single syringe for prolonged periods is discouraged due to potential molecular degradation.',
            },
          },
          {
            '@type': 'Question',
            name: 'What is the typical duration of a tissue repair cycle?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Most research protocols evaluate subjects over a 4 to 8-week cycle, depending on the severity of the musculoskeletal or dermal injury being studied.',
            },
          },
          {
            '@type': 'Question',
            name: 'Are there any known contraindications for BPC-157?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Because BPC-157 heavily promotes angiogenesis, there is theoretical concern regarding its use in models with active neoplastic conditions (cancer), as tumors also rely on angiogenesis for growth.',
            },
          },
          {
            '@type': 'Question',
            name: 'How does GHK-Cu benefit hair follicle research?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'GHK-Cu has been shown to enlarge hair follicle size and stimulate blood flow to the scalp by upregulating local VEGF, making it highly valuable in androgenetic alopecia models.',
            },
          },
          {
            '@type': 'Question',
            name: 'Does TB-500 cross the blood-brain barrier?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'No, TB-500 is a large molecular structure that does not readily cross the blood-brain barrier, which confines its actin-modulating effects primarily to peripheral tissues.',
            },
          },
          {
            '@type': 'Question',
            name: 'How should BPC-157 be stored?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Lyophilized BPC-157 is stable at room temperature for several weeks but should be stored in a freezer for long-term preservation. Once reconstituted, it must be refrigerated.',
            },
          },
          {
            '@type': 'Question',
            name: 'Can BPC-157 heal nerve damage?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Emerging research indicates that BPC-157 possesses profound neuroprotective capabilities, actively promoting the regeneration of peripheral nerves post-injury.',
            },
          },
          {
            '@type': 'Question',
            name: 'Why is TB-500 so effective for muscle tears?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'TB-500 regulates actin, a protein essential for muscle contraction and cell structure. By optimizing actin pathways, it allows muscle fibers to regenerate without the deposition of stiff scar tissue.',
            },
          },
          {
            '@type': 'Question',
            name: 'Does GHK-Cu influence anxiety models?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Recent genomic studies suggest that GHK-Cu significantly alters gene expression in the brain associated with anxiety and pain response, offering anxiolytic effects.',
            },
          },
          {
            '@type': 'Question',
            name: 'What is the standard dose for GHK-Cu?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'Standard research protocols typically evaluate GHK-Cu at 2mg to 5mg daily, monitoring for systemic copper toxicity if run for extended durations.',
            },
          },
          {
            '@type': 'Question',
            name: 'Is a post-cycle therapy (PCT) required after these peptides?',
            acceptedAnswer: {
              '@type': 'Answer',
              text: 'No. Unlike anabolic-androgenic compounds, BPC-157, TB-500, and GHK-Cu do not suppress the bodys natural endocrine HPTA axis, so no post-cycle therapy is required.',
            },
          },
        ],
      },
    },
  ],
}
